cholera

Emergent BioSolutions

Emergent sells 3 vaccines to Bavarian Nordic for $270M-plus

After a tough third quarter, Emergent BioSolutions is gaining much-needed cash with an asset sale.

Fraiser Kansteiner Feb 15, 2023 8:56am

merger and acquisition

Acquisitive Emergent BioSolutions buys PaxVax for $270M

Aug 13, 2018 12:25pm

cdc

CDC recommends PaxVax vaccine for travelers to cholera-active areas

May 16, 2017 5:55pm

cholera

ACIP greenlights PaxVax's cholera vaccine

Jun 23, 2016 4:05pm

Cholera

PaxVax's cholera vaccine wins FDA nod

Jun 10, 2016 7:54pm